A.V. KABILOVA¹, L.N. MINGAZETDINOVA², E.G. MUTALOVA²

 ¹Dyurtyuli Central District Hospital, Dyurtyuli

²Bashkir State Medical University, Ufa

 Contact details:

Kabilova A.V. — Head of the Office for temporary disability examination

Address: 27 Lenin St., Dyurtyuli, Russian Federation, 452320, tel.: +7-917-496-47-71, е-mail: kabilovaav@yandex.ru

The purpose — to study individual risk factors and their influence on the course of rheumatoid arthritis (RA) and ankylosing spondylitis (AS).

Material and methods. Patients with RA and AS took part in the research; the group of comparison was practically healthy people. We evaluated clinical condition and laboratory indicators (the level of cytokines, lymphocyte subpopulation, rheumatoid factor, antibodies to the cyclic citrullinated peptide, S-reactive protein, proinflammatory cytokines, monocyte-macrophage protein, vascular endothelial factor, and cell cycle analysis). The obtained data were processed with Statistics 7.0 software. The results were considered to be statistically reliable at р < 0.05.

Results. Hyper production of proinflammatory cytokines was marked in sick patients compared with healthy ones. The analysis of peripheral blood lymphocytes in patients showed their excess in comparison to healthy people. The assessment of lymphocytes ability for blast transformation defined the lymphocytes activation with the growth of cells at apoptosis stage (G1-phase); with the decrease in the proportion of resting cells (GO-phase) in patients, the activation coefficient was significantly growing. More apoptosis activation markers were found in the group of RA patients. Changes in apoptosis were revealed with the decreased proportion of lymphocytes in unstimulated cultures of patients; at the same time, the amount of cells in apoptosis increased four times in the examined patients compared to the healthy ones.

Conclusions. In patients with RA and AS, changes of the factors of the immune system wee noted as the amount of pro-inflammatory cytokines IL—1β, IL-6, TNF—α and the concentration of MSR-1, VEGF, SPB, RF increased. The enhancement of cellular apoptosis is due to the increase of the apoptosis inducer — CD95+9(FaS) lymphocytes, TNF- α, the growth of cells at pre-synthetic stage of apoptosis G1-phase and the activation coefficient.

Key words: rheumatic diseases, rheumatoid arthritis, ankylosing spondylitis, pathogenesis, markers of inflammation, apoptosis.

(For citation: Kabilova A.V., Mingazetdinova L.N., Mutalova E.G. Assessment of risk factors in the course of rheumatoid arthritis and ankylosing spondylitis. Practical medicine. 2022. Vol. , № , P.)

REFERENCES

1. Lila A.M., Olyunin Yu.A., Gordeev A.V. Assessment of the status of patients with rheumatoid arthritis. Current trends. Sovremennaya revmatologiya, 2020,  vol. 14, no. 2, pp. 7–13 (in Russ.).
2. Smolen J.S., Kerschbaumer A., Aletaha D. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying anti-rheumatic drugs: 2019 update. Annals of the Rheumatic Diseases, 2020,  vol. 79 (6),  pp. 685–699.
3. Potapnev M.P. Autophagy, apoptosis, cell necrosis and immune recognition of self and nonself. Immunologiya, 2014,  vol. 35, no. 2,  pp. 95–102 (in Russ.).
4. Avdeeva A.S., Novikov A.A., Aleksandrova E.N. et al. Relationship between cytokine levels and disease activity, autoantibody levels, and destructive joint changes in early rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya, 2015,  vol. 53, no. 4,  pp. 385–390 (in Russ.).
5. Nasonov E.L. Problems of immunopathology of rheumatoid arthritis: evolution of the disease. Nauchno-prakticheskaya revmatologiya, 2017,  vol. 55, no. 3,  pp. 277–294 (in Russ.).
6. Revmatologiya: natsional’noe rukovodstvo, pod red. E.L. Nasonova [Rheumatology: national guidelines, ed. by E.L. Nasonov]. Moscow: GEOTAR-Media, 2008. 720 p.
7. Guseva I.A., Demidova N.V., Soroka N.E. et al. Immunological aspects of early rheumatoid arthritis. Vestnik Rossiyskoy akademii meditsinskikh nauk, 2013,  no. 4,  pp. 36–43 (in Russ.).
8. Novikov A.A. Mnogoparametricheskiy analiz laboratornykh biomarkerov v diagnostike revmatoidnogo artrita: avtoref. dis. … d-ra biol. nauk [Multiparametric analysis of laboratory biomarkers in the diagnosis of rheumatoid arthritis. Synopsis of dis. Dr biol. sciences]. Moscow, 2014. 48 p.
9. Smolen J.S., Aletaha D., Redlich K. The pathogenesis of rheumatoid arthritis: new insights from old clinical data? Nat. Rev. Rheumatol, 2012,  vol. 8 (4),  pp. 235–243.
10. Godzenko A.A. Ankiloziruyushchiy spondilit [Ankylosing spondylitis]. Revmatologiya. Klinicheskie lektsii. Moscow: Litterra, 2014. P. 124.